Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

[Advanced glycation end-products: new markers of renal dysfunction in patients with chronic heart failure].

Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, Moure-González M, Seoane-Blanco A, Varela-Román A, Alvarez E, González-Juanatey JR.

Med Clin (Barc). 2011 Apr 30;136(12):513-21. doi: 10.1016/j.medcli.2010.06.030. Epub 2011 Feb 12. Spanish.

PMID:
21316717
2.

Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure.

Damman K, van der Harst P, Smilde TD, Voors AA, Navis G, van Veldhuisen DJ, Hillege HL.

Heart. 2012 Feb;98(4):319-24. doi: 10.1136/heartjnl-2011-300692. Epub 2011 Oct 29.

PMID:
22038544
3.

Cystatin C in acute heart failure without advanced renal impairment.

Naruse H, Ishii J, Kawai T, Hattori K, Ishikawa M, Okumura M, Kan S, Nakano T, Matsui S, Nomura M, Hishida H, Ozaki Y.

Am J Med. 2009 Jun;122(6):566-73. doi: 10.1016/j.amjmed.2008.10.042. Epub 2009 Apr 24.

PMID:
19393984
4.

Renal function largely influences Galectin-3 prognostic value in heart failure.

Zamora E, Lupón J, de Antonio M, Galán A, Domingo M, Urrutia A, Troya M, Bayes-Genis A.

Int J Cardiol. 2014 Nov 15;177(1):171-7. doi: 10.1016/j.ijcard.2014.09.011. Epub 2014 Oct 11.

PMID:
25499371
5.

Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C.

Zamora E, Lupón J, de Antonio M, Vila J, Peñafiel J, Galán A, Urrutia A, Domingo M, Bayes-Genis A.

Clin Chem. 2014 Mar;60(3):481-9. doi: 10.1373/clinchem.2013.212951. Epub 2013 Nov 19.

6.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr.

J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.

7.

Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification.

Zamora E, Lupón J, de Antonio M, Vila J, Galán A, Gastelurrutia P, Urrutia A, Bayes-Genis A.

PLoS One. 2012;7(12):e51234. doi: 10.1371/journal.pone.0051234. Epub 2012 Dec 11.

8.

Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.

Flores-Blanco PJ, Manzano-Fernández S, Pérez-Calvo JI, Pastor-Pérez FJ, Ruiz-Ruiz FJ, Carrasco-Sánchez FJ, Morales-Rull JL, Pascual-Figal D, Galisteo-Almeda L, Januzzi JL.

Clin Cardiol. 2015 Feb;38(2):106-13. doi: 10.1002/clc.22362. Epub 2015 Feb 6.

9.

Cystatin C: influence of perfusion and myocardial injury on early (<24 h) renal function after pediatric cardiac surgery.

Vassalos A, Young D, MacArthur K, Pollock J, Lyall F, Danton MH.

Paediatr Anaesth. 2011 Dec;21(12):1185-91. doi: 10.1111/j.1460-9592.2011.03654.x. Epub 2011 Aug 11.

PMID:
21831111
10.

β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure.

Manzano-Fernández S, Januzzi JL Jr, Boronat-Garcia M, Bonaque-González JC, Truong QA, Pastor-Pérez FJ, Muñoz-Esparza C, Pastor P, Albaladejo-Otón MD, Casas T, Valdés M, Pascual-Figal DA.

J Am Coll Cardiol. 2011 Feb 15;57(7):849-58. doi: 10.1016/j.jacc.2010.08.644.

11.

Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE.

Raposeiras-Roubín S, Rodiño-Janeiro BK, Grigorian-Shamagian L, Moure-González M, Seoane-Blanco A, Varela-Román A, Alvarez E, González-Juanatey JR.

Eur J Heart Fail. 2010 Oct;12(10):1092-100. doi: 10.1093/eurjhf/hfq117. Epub 2010 Aug 3.

12.

Glomerular filtration rate estimation in patients with advanced chronic renal insufficiency based on serum cystatin C levels.

Schück O, Teplan V, Jabor A, Stollova M, Skibova J.

Nephron Clin Pract. 2003;93(4):c146-51.

PMID:
12759583
13.

Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.

Heidland A, Sebeková K, Frangiosa A, De Santo LS, Cirillo M, Rossi F, Cotrufo M, Perna A, Klassen A, Schinzel R, De Santo NG.

Heart. 2004 Nov;90(11):1269-74.

14.

Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy.

Hosoda J, Ishikawa T, Matsushita K, Matsumoto K, Kimura Y, Miyamoto M, Ogawa H, Takamura T, Sugano T, Ishigami T, Uchino K, Kimura K, Umemura S.

J Cardiol. 2012 Oct;60(4):301-5. doi: 10.1016/j.jjcc.2012.06.001. Epub 2012 Jul 2.

15.

Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure.

Shiba N, Matsuki M, Takahashi J, Tada T, Watanabe J, Shimokawa H.

Circ J. 2008 Feb;72(2):173-8.

16.

Serum cystatin C is a potential endogenous marker for the estimation of renal function in male gout patients with renal impairment.

Choe JY, Park SH, Kim SK.

J Korean Med Sci. 2010 Jan;25(1):42-8. doi: 10.3346/jkms.2010.25.1.42. Epub 2009 Dec 26.

17.

Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.

Van Den Noortgate NJ, Janssens WH, Delanghe JR, Afschrift MB, Lameire NH.

J Am Geriatr Soc. 2002 Jul;50(7):1278-82.

PMID:
12133025
18.

Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.

Linzbach S, Samigullin A, Yilmaz S, Tsioga M, Zeiher AM, Spyridopoulos I.

Am J Cardiol. 2009 Apr 15;103(8):1128-33. doi: 10.1016/j.amjcard.2009.01.009. Epub 2009 Mar 4.

PMID:
19361601
19.

Prevalence of renal dysfunction and its influence on functional capacity in elderly patients with stable chronic heart failure.

Stanojević D, Apostolović S, Janković-Tomasević R, Salinger-Martinović S, Pavlović M, Zivković M, Bozinović N, Kutlesić-Kurtović D.

Vojnosanit Pregl. 2012 Oct;69(10):840-5.

PMID:
23155603
20.

Prognostic value of renin and prorenin in heart failure patients with decreased kidney function.

Szymanski MK, Damman K, van Veldhuisen DJ, van Gilst WH, Hillege HL, de Boer RA.

Am Heart J. 2011 Sep;162(3):487-93. doi: 10.1016/j.ahj.2011.06.001. Epub 2011 Jul 26.

PMID:
21884865

Supplemental Content

Support Center